Healthcare -
Biotechnology - NASDAQ - US
$ 24.05
-4.37 %
$ 2.99 B
Market Cap
-15.03
P/E
APLS - OTHER CURRENT LIABILITIES
Other Current Liabilities APLS - Apellis Pharmaceuticals, Inc.
204 M
LAST VALUE
35.55%
2 YEAR CAGR
109.03%
5 YEAR CAGR
90.53%
10 YEAR CAGR